Conatus Pharmaceuticals (CNAT) Earnings

Mar 11Confirmed
May 2018
Aug 2018
Nov 2018
Mar 2019
-0.2
-0.18
-0.15
-0.13

Details

Expected EPS
-0.14
Actual EPS
-0.13
Surprise EPS
0.01
Surprise Percent
+7.14%

Description

⁨Conatus Pharmaceuticals⁩ (⁦CNAT⁩) has reported earnings of ⁦-0.13⁩ per share for ⁦null⁩.

0 Comments

Share your thoughts